|
SE9904724D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission I
|
|
SE9904723D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
USRE46117E1
(en)
|
1999-12-22 |
2016-08-23 |
Teva Pharmaceuticals International Gmbh |
Modulators of dopamine neurotransmission
|
|
CA2432988A1
(en)
|
2001-01-23 |
2002-08-01 |
Cristina Garcia-Paredes |
Melanocortin receptor agonists
|
|
ES2247298T3
(es)
|
2001-01-23 |
2006-03-01 |
Eli Lilly And Company |
Derivados de piperazina y piperidina como agonistas del receptor de melanocortina.
|
|
EP1368339A1
(en)
|
2001-01-23 |
2003-12-10 |
Eli Lilly & Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
CA2438272A1
(en)
|
2001-03-02 |
2002-10-10 |
John Macor |
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
|
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US7115607B2
(en)
*
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
AU2002331064B2
(en)
|
2001-08-10 |
2007-08-23 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
US7456184B2
(en)
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
US7354923B2
(en)
|
2001-08-10 |
2008-04-08 |
Palatin Technologies, Inc. |
Piperazine melanocortin-specific compounds
|
|
UA81749C2
(uk)
*
|
2001-10-04 |
2008-02-11 |
Х. Луннбек А/С |
Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
|
|
WO2003061660A1
(en)
*
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
|
AU2003230367A1
(en)
*
|
2002-05-10 |
2003-11-11 |
Neurocrine Biosciences, Inc. |
Substituted piperazine as melanocortin receptors ligands
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
WO2004024720A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
WO2004081643A1
(en)
*
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2004078717A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
US20060178403A1
(en)
*
|
2003-03-07 |
2006-08-10 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
WO2004083235A2
(en)
*
|
2003-03-19 |
2004-09-30 |
Exelixis Inc. |
Tie-2 modulators and methods of use
|
|
EP1460069A1
(en)
*
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
|
EP1468999A1
(en)
*
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
CN1764458A
(zh)
|
2003-03-26 |
2006-04-26 |
麦克公司 |
作为黑皮质素－4受体激动剂的双环哌啶衍生物
|
|
EP1644347A1
(en)
*
|
2003-06-20 |
2006-04-12 |
Arena Pharmaceuticals, Inc. |
N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT sb 2C /sb RECEPTOR ASSOCIATED DISEASES
|
|
ATE547404T1
(de)
|
2003-09-22 |
2012-03-15 |
Msd Kk |
Piperidinderivate
|
|
US20050119252A1
(en)
*
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050192286A1
(en)
*
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
EP1538159A1
(en)
*
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
|
CN100526301C
(zh)
*
|
2003-12-26 |
2009-08-12 |
卫材R&D管理有限公司 |
1,2-二(环式基)取代苯化合物
|
|
US7410971B2
(en)
|
2003-12-26 |
2008-08-12 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic)substituted benzene compounds
|
|
MY140489A
(en)
*
|
2003-12-26 |
2009-12-31 |
Eisai R&D Man Co Ltd |
1,2-di (cyclic) substituted benzene compounds
|
|
US20060276465A1
(en)
*
|
2003-12-26 |
2006-12-07 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic) substituted benzene compounds
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
|
SE0401465D0
(sv)
|
2004-06-08 |
2004-06-08 |
Carlsson A Research Ab |
New substituted piperdines as modulators of dopamine neurotransmission
|
|
US7851629B2
(en)
|
2004-06-08 |
2010-12-14 |
Nsab, Filial Af Neurosearch Sweden Ab, Sverige |
Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
|
ES2346452T3
(es)
*
|
2004-06-08 |
2010-10-15 |
Nsab, Filial Af Neurosearch Sweden Ab, Sverige |
Nuevas fenilpiperidinas/piperazinas disustituidas utilizadas como moduladores de la neurotransmision de la dopamina.
|
|
RU2366654C2
(ru)
*
|
2004-06-08 |
2009-09-10 |
ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ |
Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии
|
|
MXPA06013941A
(es)
|
2004-06-08 |
2007-12-10 |
Neurosearch Sweden Ab |
Fenilpiperidinas disustituidas, novedosas, como moduladores de la neurotransmision de dopamina y serotonina.
|
|
CA2584831C
(en)
|
2004-10-13 |
2013-09-17 |
Neurosearch Sweden Ab |
Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
CN101068798B
(zh)
*
|
2004-12-20 |
2010-05-12 |
卫材R&D管理有限公司 |
1-环丙基甲基-4-[2-(3,3,5,5-四甲基环己基)苯基]哌嗪的盐及结晶
|
|
BRPI0610580B8
(pt)
|
2005-05-30 |
2021-05-25 |
Banyu Pharma Co Ltd |
composto derivado de piperidina
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
MY144974A
(en)
*
|
2005-06-14 |
2011-11-30 |
Eisai R&D Man Co Ltd |
1,2-di(cyclic) substituted benzene derivatives
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
EP1940842B1
(en)
|
2005-09-29 |
2012-05-30 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
SE529246C2
(sv)
|
2005-10-13 |
2007-06-12 |
Neurosearch Sweden Ab |
Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
|
|
AU2006304305B2
(en)
|
2005-10-18 |
2010-04-01 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
JP2009512715A
(ja)
|
2005-10-21 |
2009-03-26 |
ノバルティス アクチエンゲゼルシャフト |
レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
ES2381205T3
(es)
|
2005-11-10 |
2012-05-24 |
Msd K.K. |
Derivado espiro aza-sustituido
|
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
|
WO2007096186A1
(en)
*
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
MX352516B
(es)
|
2006-07-05 |
2017-04-06 |
Fibrotech Therapeutics Pty Ltd |
Compuestos terapeuticos.
|
|
US8173629B2
(en)
|
2006-09-22 |
2012-05-08 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
US20090247560A1
(en)
|
2006-09-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
JP5319518B2
(ja)
|
2007-04-02 |
2013-10-16 |
Ｍｓｄ株式会社 |
インドールジオン誘導体
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
EP2019100A1
(en)
*
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
EP2020405A1
(en)
*
|
2007-07-30 |
2009-02-04 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
EP2264026A4
(en)
|
2008-03-06 |
2012-03-28 |
Msd Kk |
ALKYLAMINOPYRIDINDERIVATE
|
|
WO2009119726A1
(ja)
|
2008-03-28 |
2009-10-01 |
萬有製薬株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
JPWO2009154132A1
(ja)
|
2008-06-19 |
2011-12-01 |
Ｍｓｄ株式会社 |
スピロジアミン−ジアリールケトオキシム誘導体
|
|
TWI433838B
(zh)
|
2008-06-25 |
2014-04-11 |
必治妥美雅史谷比公司 |
作為趨化因子受體活性調節劑之六氫吡啶衍生物
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
EP2319841A1
(en)
|
2008-07-30 |
2011-05-11 |
Msd K.K. |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
|
EP2348857B1
(en)
|
2008-10-22 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
UA99555C2
(en)
|
2008-11-12 |
2012-08-27 |
Элджи Лайф Саенсез Лтд. |
Melanocortin receptor agonists
|
|
EP2358200A4
(en)
|
2008-11-17 |
2012-05-16 |
Merck Sharp & Dohme |
SUBSTITUTED BICYCLIC AMINES FOR THE TREATMENT OF DIABETES
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
CN102574843B
(zh)
|
2009-10-22 |
2015-06-17 |
法博太科制药有限公司 |
抗纤维化剂的稠环类似物
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
WO2011137024A1
(en)
|
2010-04-26 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Novel spiropiperidine prolylcarboxypeptidase inhibitors
|
|
EP2568812B1
(en)
|
2010-05-11 |
2016-10-26 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
WO2011156246A1
(en)
|
2010-06-11 |
2011-12-15 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
US8642622B2
(en)
|
2010-06-16 |
2014-02-04 |
Bristol-Myers Squibb Company |
Piperidinyl compound as a modulator of chemokine receptor activity
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012100342A1
(en)
|
2011-01-27 |
2012-08-02 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
|
SG192941A1
(en)
|
2011-02-25 |
2013-09-30 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
TWI579272B
(zh)
|
2011-12-08 |
2017-04-21 |
梯瓦製藥國際有限責任公司 |
普多比啶（ｐｒｉｄｏｐｉｄｉｎｅ）之氫溴酸鹽
|
|
AU2013216354B2
(en)
|
2012-02-02 |
2017-08-31 |
Idorsia Pharmaceuticals Ltd |
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
|
|
AU2013243461A1
(en)
|
2012-04-04 |
2014-11-06 |
Teva Pharmaceuticals International Gmbh |
Pharmaceutical compositions for combination therapy
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
EP2746259A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
EP2746260A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
KR20150118158A
(ko)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 비시클릭 화합물
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
BR112015027164B1
(pt)
|
2013-06-05 |
2023-03-21 |
Shanghai Lumosa Therapeutics Co., Ltd |
Novos compostos com tripla atividade de trombólise, antitrombótica e neutralização de radical, e sua síntese, nanoestrutura e uso
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
|
JP6330040B2
(ja)
|
2013-07-22 |
2018-05-23 |
イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
１−（ピペラジン−１−イル）−２−（［１，２，４］トリアゾール−１−イル）−エタノン誘導体
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
KR102431436B1
(ko)
|
2014-08-29 |
2022-08-10 |
테스 파마 에스.알.엘. |
α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
|
PL3245203T3
(pl)
|
2015-01-15 |
2019-05-31 |
Idorsia Pharmaceuticals Ltd |
Pochodne hydroksyalkilopiperazyny jako modulatory receptora cxcr3
|
|
CN105348204B
(zh)
*
|
2015-11-18 |
2018-09-14 |
乳源瑶族自治县大众药品贸易有限公司 |
1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途
|
|
CN105294554B
(zh)
*
|
2015-11-18 |
2017-11-07 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
CN105461635B
(zh)
*
|
2015-11-18 |
2018-06-08 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
WO2018069532A1
(en)
|
2016-10-14 |
2018-04-19 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
EP3558298B1
(en)
|
2016-12-20 |
2026-03-11 |
Merck Sharp & Dohme LLC |
Antidiabetic spirochroman compounds
|
|
JP7185631B2
(ja)
|
2017-02-03 |
2022-12-07 |
サータ セラピューティクス プロプライエタリー リミテッド |
抗線維化化合物
|
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
EP3821947A1
(en)
*
|
2019-11-13 |
2021-05-19 |
Libra Therapeutics, Inc. |
Heterocyclic trpml1 agonists
|
|
TW202136219A
(zh)
*
|
2019-12-19 |
2021-10-01 |
美商卡司馬療法公司 |
Trpml調節劑
|
|
AR129265A1
(es)
|
2022-05-12 |
2024-08-07 |
Syngenta Crop Protection Ag |
Compuestos de alcoxi-heteroaril-carboxamida o tioamida
|
|
WO2024033374A1
(en)
|
2022-08-11 |
2024-02-15 |
Syngenta Crop Protection Ag |
Novel arylcarboxamide or arylthioamide compounds
|
|
WO2024089216A1
(en)
|
2022-10-27 |
2024-05-02 |
Syngenta Crop Protection Ag |
Novel sulfur-containing heteroaryl carboxamide compounds
|
|
JP2026500298A
(ja)
|
2022-12-15 |
2026-01-06 |
シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト |
殺有害生物剤として有用である新規な二環式カルボキサミド化合物
|
|
AR131541A1
(es)
|
2023-01-07 |
2025-04-09 |
Syngenta Crop Protection Ag |
Compuestos de carboxamida novedosos
|
|
WO2025032129A1
(en)
|
2023-08-08 |
2025-02-13 |
Syngenta Crop Protection Ag |
Novel aminoindane and aminotetraline compounds
|
|
WO2025104032A1
(en)
|
2023-11-14 |
2025-05-22 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2025109114A1
(en)
|
2023-11-24 |
2025-05-30 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2025149637A1
(en)
|
2024-01-12 |
2025-07-17 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
PY2501648A
(es)
|
2024-01-12 |
2025-10-31 |
Syngenta Crop Protection Ag |
Nuevos compuestos de carboxamida
|
|
WO2026008750A1
(en)
|
2024-07-05 |
2026-01-08 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|